<p>BMI, body mass index; SD, standard deviation; M, male; F, female; WC, waist circumference; SBP, systolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase; HBsAg, hepatitis B surface antigen; FLI, fatty liver index.</p>*<p>Expressed as mean ± standard deviation.</p
<p>NAFLD = non-alcohol fatty liver disease; BMI = body mass index; FM = fat mass of the whole body; ...
<p>The prevalence rates of fatty liver in all subgroups are expressed as prevalence rate (standard e...
*<p>Data are expressed as mean ± standard deviation.</p><p>AHB, Acute hepatitis B; CHB, Chronic hepa...
<p>± standard deviation. *<i>P</i>-value, between two groups with and without fatty liver by Student...
<p>Data are means ± SE or percentages or percentages or median (25th to 75th percentiles).</p>a<p>P<...
<p>Data are expressed as mean±standard deviation.</p><p>BMI, Body mass index; HOMA-IR, homeostasis m...
<p><b>(A)</b> Comparison of ultrasonogrphic fatty liver prevalence rate between male and female subj...
Comparison of demographic, clinical, and biochemical data, and liver stiffness and CAP of subjects f...
<p>CHC, chronic hepatitis C; IBD, inflammatory bowel disease; BMI, Body mass index; AST, aspartate a...
Characteristics of overall study population and comparison between subjects with and without non-alc...
<p>HBV, hepatitis B virus; BMI, body mass index; SD, standard deviation; M, male; F, female; WC, wai...
<p>Abbreviations: AST: aspartate aminotransferase; ALT: alanine aminotransferase; qHBsAg: quantitati...
<p>Abbreviations: SBP, systolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipo...
Comparison of characteristics of subjects with risk factors for NAFLD categorized according to liver...
This figure refers to a subgroup of underweight individuals (n = 12) without inflammatory bowel dise...
<p>NAFLD = non-alcohol fatty liver disease; BMI = body mass index; FM = fat mass of the whole body; ...
<p>The prevalence rates of fatty liver in all subgroups are expressed as prevalence rate (standard e...
*<p>Data are expressed as mean ± standard deviation.</p><p>AHB, Acute hepatitis B; CHB, Chronic hepa...
<p>± standard deviation. *<i>P</i>-value, between two groups with and without fatty liver by Student...
<p>Data are means ± SE or percentages or percentages or median (25th to 75th percentiles).</p>a<p>P<...
<p>Data are expressed as mean±standard deviation.</p><p>BMI, Body mass index; HOMA-IR, homeostasis m...
<p><b>(A)</b> Comparison of ultrasonogrphic fatty liver prevalence rate between male and female subj...
Comparison of demographic, clinical, and biochemical data, and liver stiffness and CAP of subjects f...
<p>CHC, chronic hepatitis C; IBD, inflammatory bowel disease; BMI, Body mass index; AST, aspartate a...
Characteristics of overall study population and comparison between subjects with and without non-alc...
<p>HBV, hepatitis B virus; BMI, body mass index; SD, standard deviation; M, male; F, female; WC, wai...
<p>Abbreviations: AST: aspartate aminotransferase; ALT: alanine aminotransferase; qHBsAg: quantitati...
<p>Abbreviations: SBP, systolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipo...
Comparison of characteristics of subjects with risk factors for NAFLD categorized according to liver...
This figure refers to a subgroup of underweight individuals (n = 12) without inflammatory bowel dise...
<p>NAFLD = non-alcohol fatty liver disease; BMI = body mass index; FM = fat mass of the whole body; ...
<p>The prevalence rates of fatty liver in all subgroups are expressed as prevalence rate (standard e...
*<p>Data are expressed as mean ± standard deviation.</p><p>AHB, Acute hepatitis B; CHB, Chronic hepa...